|
1
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Teixeira VP, Blattner SM, Li M, Anders HJ,
Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP and
Kretzler M: Functional consequences of integrin-linked kinase
activation in podocyte damage. Kidney Int. 67:514–523. 2005.
View Article : Google Scholar
|
|
3
|
Dai C, Stolz DB, Kiss LP, Monga SP,
Holzman LB and Liu Y: Wnt/beta-catenin signaling promotes podocyte
dysfunction and albuminuria. J Am Soc Nephrol. 20:1997–2008. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai J, Schleidt S, Pelta-Heller J,
Hutchings D, Cannarsa G and Iacovitti L: BMP and TGF-β pathway
mediators are critical upstream regulators of Wnt signaling during
midbrain dopamine differentiation in human pluripotent stem cells.
Dev Biol. 376:62–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kato H, Gruenwald A, Suh JH, Miner JH,
Barisoni-Thomas L, Taketo MM, Faul C, Millar SE, Holzman LB and
Susztak K: Wnt/β-catenin pathway in podocytes integrates cell
adhesion, differentiation, and survival. J Biol Chem.
286:26003–26015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jackson RJ and Standart N: How do
microRNAs regulate gene expression? Sci STKE. 2007:re12007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Long J, Wang Y, Wang W, Chang BH and
Danesh FR: Identification of microRNA-93 as a novel regulator of
vascular endothelial growth factor in hyperglycemic conditions. J
Biol Chem. 285:23457–23465. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen YQ, Wang XX, Yao XM, Zhang DL, Yang
XF, Tian SF and Wang NS: MicroRNA-195 promotes apoptosis in mouse
podocytes via enhanced caspase activity driven by BCL2
insufficiency. Am J Nephrol. 34:549–559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu J, Zheng C, Fan Y, Zeng C, Chen Z, Qin
W, Zhang C, Zhang W, Wang X, Zhu X, et al: Downregulation of
microRNA-30 facilitates podocyte injury and is prevented by
glucocorticoids. J Am Soc Nephrol. 25:92–104. 2014. View Article : Google Scholar :
|
|
10
|
Kato M, Zhang J, Wang M, Lanting L, Yuan
H, Rossi JJ and Natarajan R: MicroRNA-192 in diabetic kidney
glomeruli and its function in TGF-beta-induced collagen expression
via inhibition of E-box repressors. Proc Natl Acad Sci USA.
104:3432–3437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung AC, Huang XR, Meng X and Lan HY:
miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc
Nephrol. 21:1317–1325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi S, Yu L, Chiu C, Sun Y, Chen J,
Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P and
Bottinger EP: Podocyte-selective deletion of dicer induces
proteinuria and glomerulosclerosis. J Am Soc Nephrol. 19:2159–2169.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nagel R, le Sage C, Diosdado B, van der
Waal M, Oude Vrielink JA, Bolijn A, Meijer GA and Agami R:
Regulation of the adenomatous polyposis coli gene by the miR-135
family in colorectal cancer. Cancer Res. 68:5795–5802. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Holleman A, Chung I, Olsen RR, Kwak B,
Mizokami A, Saijo N, Parissenti A, Duan Z, Voest EE and Zetter BR:
miR-135a contributes to paclitaxel resistance in tumor cells both
in vitro and in vivo. Oncogene. 30:4386–4398. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou W, Li X, Liu F, Xiao Z, He M, Shen S
and Liu S: MiR-135a promotes growth and invasion of colorectal
cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys
Sin (Shanghai). 44:838–846. 2012. View Article : Google Scholar
|
|
16
|
Yamada Y, Hidaka H, Seki N, Yoshino H,
Yamasaki T, Itesako T, Nakagawa M and Enokida H: Tumor-suppressive
microRNA-135a inhibits cancer cell proliferation by targeting the
c-MYC oncogene in renal cell carcinoma. Cancer Sci. 104:304–312.
2013. View Article : Google Scholar
|
|
17
|
Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y,
Zhu W, Su X, Zhou Y, Qiu P, et al Yan G: MiR-135a functions as a
selective killer of malignant glioma. Oncogene. 31:3866–3874. 2012.
View Article : Google Scholar
|
|
18
|
Anderegg A, Lin HP, Chen JA, Caronia-Brown
G, Cherepanova N, Yun B, Joksimovic M, Rock J, Harfe BD, Johnson R
and Awatramani R: An Lmx1b-miR135a2 regulatory circuit modulates
Wnt1/Wnt signaling and determines the size of the midbrain
dopaminergic progenitor pool. PLoS Genet. 9:e10039732013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He F, Peng F, Xia X, Zhao C, Luo Q, Guan
W, Li Z, Yu X and Huang F: MiR-135a promotes renal fibrosis in
diabetic nephropathy by regulating TRPC1. Diabetologia.
57:1726–1736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fogo AB: Animal models of FSGS: Lessons
for pathogenesis and treatment. Semin Nephrol. 23:161–171. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Wang YP, Tay YC and Harris DC:
Progressive adriamycin nephropathy in mice: Sequence of histologic
and immunohistochemical events. Kidney Int. 58:1797–1804. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ni L, Saleem M and Mathieson PW: Podocyte
culture: Tricks of the trade. Nephrology (Carlton). 17:525–531.
2012. View Article : Google Scholar
|
|
23
|
Mundel P, Reiser J, Zúñiga Mejía Borja A,
Pavenstädt H, Davidson GR, Kriz W and Zeller R: Rearrangements of
the cytoskeleton and cell contacts induce process formation during
differentiation of conditionally immortalized mouse podocyte cell
lines. Exp Cell Res. 236:248–258. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kolfschoten IG, van Leeuwen B, Berns K,
Mullenders J, Beijersbergen RL, Bernards R, Voorhoeve PM and Agami
R: A genetic screen identifies PITX1 as a suppressor of RAS
activity and tumorigenicity. Cell. 121:849–858. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bae GU, Lee JR, Kim BG, Han JW, Leem YE,
Lee HJ, Ho SM, Hahn MJ and Kang JS: Cdo interacts with APPL1 and
activates Akt in myoblast differentiation. Mol Biol Cell.
21:2399–2411. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bae GU, Kim BG, Lee HJ, Oh JE, Lee SJ,
Zhang W, Krauss RS and Kang JS: Cdo binds Abl to promote
p38alpha/beta mitogen-activated protein kinase activity and
myogenic differentiation. Mol Cell Biol. 29:4130–4143. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pollak MR: Inherited podocytopathies: FSGS
and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol.
13:3016–3023. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Jarad G, Tripathi P, Pan M,
Cunningham J, Martin DR, Liapis H, Miner JH and Chen F: Activation
of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc
Nephrol. 21:1657–1666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Welsh GI and Saleem MA: The podocyte
cytoskeleton - key to a functioning glomerulus in health and
disease. Nat Rev Nephrol. 8:14–21. 2012. View Article : Google Scholar
|
|
30
|
Wang D, Dai C, Li Y and Liu Y: Canonical
Wnt/β-catenin signaling mediates transforming growth
factor-β1-driven podocyte injury and proteinuria. Kidney Int.
80:1159–1169. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Asanuma K: The role of podocyte injury in
chronic kidney disease. Nihon Rinsho Meneki Gakkai Kaishi.
38:26–36. 2015.In Japanese. View Article : Google Scholar
|
|
32
|
Kato H and Susztak K: Repair problems in
podocytes: Wnt, Notch, and glomerulosclerosis. Semin Nephrol.
32:350–356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Faul C, Donnelly M, Merscher-Gomez S,
Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim
K, Reiser J and Mundel P: The actin cytoskeleton of kidney
podocytes is a direct target of the antiproteinuric effect of
cyclosporine A. Nat Med. 14:931–938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fornoni A, Sageshima J, Wei C,
Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A,
Ciancio G, Chen L, et al: Rituximab targets podocytes in recurrent
focal segmental glomerulosclerosis. Sci Translat Med.
3:85ra462011.
|
|
35
|
Nakamura T, Hamada F, Ishidate T, Anai K,
Kawahara K, Toyoshima K and Akiyama T: Axin, an inhibitor of the
Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and
APC and reduces the beta-catenin level. Genes Cells. 3:395–403.
1998. View Article : Google Scholar : PubMed/NCBI
|
